Align Technology, Inc.

NASDAQ:ALGN

Medical - Devices

Healthcare
$163.96 -3.34%

-$5.99 today

Market cap
$11.56B
Beta
1.67
P/E (TTM)
28.8
EPS (TTM)
$6.02
52W Low $122.00High $208.31

Volume 0.89M

Average 1.05M

ALGN EBITDA Margin

EBITDA as a percentage of revenue.

Align Technology, Inc.NASDAQ: ALGN

EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026

EBITDA Margin narrows to 8.6%

EBITDA Margin was 8.6% in Q2 FY2026, down 12.6 pp from a year earlier. On a trailing-twelve-month basis it was 19.0%, down 1.3 pp year over year. Over 3 fiscal years it narrowed by 0.5 pp.

Context

  • EBITDA Margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 12 analysts of 34.2% for the fiscal year ending Dec 2026, up from 20.4% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
8.6%-11.2 pp QoQ
Last fiscal yearDec 2025
20.4%-0.0 pp YoY
LTMJun 2026
19.0%-1.3 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-12.6 pp+7.4 pp+20.0 pp
1 year-0.0 pp+13.8 pp+13.9 pp
3 years-0.5 pp+14.9 pp+15.4 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
20.4%
Year-over-year change
-0.0pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How ALGN compares with its peers on the latest reported figures

  • ALGN's LTM Jun 2026 EBITDA Margin of 19.0% is the 2nd highest of the 3 companies compared; the peer median is 12.8%.
  • Its year-over-year change of -1.3 pp is the lowest of 3, against a peer median of +13.3 pp.
  • Over three fiscal years its change of -0.5 pp compares with a peer median of +3.7 pp.
ALGN Competitors Peer median
EBITDA Margin for ALGN and competitors
Company Period LTM level YoY 3-year change
NVSTEnvista Holdings CorpLTM Oct 202629.0% +16.5 pp-8.2 pp
ALGNAlign Technology, Inc.LTM Jun 202619.0% -1.3 pp-0.5 pp
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026-3.5% +10.1 pp+15.6 pp
Peer median (excluding ALGN) 12.8%+13.3 pp+3.7 pp

Competitors are the stored peer set for ALGN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue3.95B3.73B3.86B4B4.03B
Cost of Revenue1.02B1.1B1.16B1.2B1.28B
Gross Profit2.94B2.63B2.71B2.8B2.76B
Gross Margin74.3%70.5%70.1%70.0%68.3%
Research & Development250.32M305.26M346.83M364.2M369.91M
Selling, General & Admin1.71B1.67B1.7B1.76B1.76B
Operating Expenses1.96B1.99B2.06B2.19B2.14B
Depreciation & Amortization108.73M125.79M142.4M145.03M237.44M
EBITDA1.12B779.84M799.06M816.8M822.72M
EBITDA Margin28.4%20.9%20.7%20.4%20.4%
Operating Income976.4M642.6M643.34M607.63M616.22M
Operating Margin24.7%17.2%16.7%15.2%15.3%
Interest Income3.1M5.37M17.26M20.22M16.05M
Interest Expense00000
Other Income / Expenses36.02M(43.54M)(2.13M)1.33M(30.93M)
Income Before Tax1.01B599.06M641.2M608.96M585.29M
Pre-Tax Margin25.6%16.0%16.6%15.2%14.5%
Income Tax Expense240.4M237.48M196.15M187.6M174.94M
Net Income772.02M361.57M445.05M421.36M410.35M
Net Margin19.5%9.7%11.5%10.5%10.2%
EPS (Basic)9.784.625.825.635.66
EPS (Diluted)9.694.615.815.625.65
Weighted Avg Shares78.92M78.19M76.43M74.88M72.54M
Weighted Avg Shares (Diluted)79.67M78.42M76.57M74.99M72.59M

Align Technology, Inc.

NASDAQ:ALGN

Intrinsic Alpha fair value

Locked

Current Price

$163.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.